Quest Diagnostics Expects 2024 Adjusted EPS Of $8.85-$8.95 Versus Prior Guidance Of $8.80-$9.00 And Consensus Of $8.85
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has updated its 2024 adjusted EPS guidance to a range of $8.85-$8.95, slightly narrowing from the previous range of $8.80-$9.00. This aligns with the consensus estimate of $8.85.
October 22, 2024 | 10:56 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Quest Diagnostics has revised its 2024 adjusted EPS guidance to $8.85-$8.95, slightly narrowing the range from the previous $8.80-$9.00. This aligns with the consensus estimate of $8.85, indicating stable expectations.
The updated EPS guidance is within the previous range and matches the consensus, suggesting no significant change in market expectations. This stability is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100